Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research

In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines a...

ver descrição completa

Detalhes bibliográficos
Autor principal: Coelho, André (author)
Outros Autores: Alvites, Rui Damásio (author), Branquinho, Mariana Vieira (author), Guerreiro, Susana G. (author), Maurício, Ana Colette (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
Cell-based therapies
Secretome
Mesenchymal stem cells
Coronavirus
SARS-CoV-2
Texto completo:http://hdl.handle.net/10400.22/16649
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/16649
Descrição
Resumo:In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines and specific treatments are not yet available. There are several strategies currently being studied for the treatment of adverse symptoms of COVID-19, that encompass Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS), extensive pulmonary inflammation, cytokine storm, and pulmonary edema, due to virus-induced pneumonia.

Registros relacionados